Every year, millions of tons of bisphenol A (BPA) are produced globally for use in plastics manufacturing. As a known health risk, recent research from Washington State University shows BPA levels in our bodies are far higher than previously detected.
Bisphenol A (BPA), an organic compound from the aromatic family, is widely used in plastics and resins. Classified as an endocrine disruptor, it appears in food packaging and containers, linked to increased risks of diabetes, cardiovascular disease, breast and prostate cancers, congenital malformations, and infertility.
Although BPA faces restrictions in countries like France, a December 2019 study in The Lancet Diabetes & Endocrinology challenges prior findings. Washington State University researchers argue that standard BPA screening methods severely underestimate exposure levels.
Using advanced protocols, the study measured average BPA levels at 51.99 nanograms (ng) per milliliter (ml)—compared to the prior 1.2 ng/ml. This indicates 48 times higher BPA presence in human organisms than previously reported.
The discrepancy stems from BPA's rapid metabolism into undetectable by-products in blood and urine. Breakthrough detection methods identified BPA even in its metabolized forms, providing a more accurate picture.
These findings signal greater health risks from BPA exposure and undermine current regulatory measures by governments worldwide.
Related Articles:
